Psychotic disorders are severe mental health disorders that cause changes in a person's way of thinking and their perception. Patients often have trouble differentiating between what they perceive and reality. Different types of psychotic disorders include schizophrenia, bipolar disorder, substance-induced psychotic disorder, delusional disorder, and brief psychotic disorder. However, this market only represents the sales of antipsychotic drugs that are used to treat schizophrenia and bipolar disorder.
Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.
Company examples: Otsuka Pharmaceutical, Lundbeck, AbbVie, Allergan plc, Recordati S.p.A., Gadeon Richter, Sumitomo Pharma, Johnson & Johnson / Janssen, Vanda Pharmaceuticals, Alkermes, Eli Lilly, AstraZeneca, and Intra-Cellular Therapies
Notes: Data was converted from local currencies using average exchange rates of the respective year.
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
Most recent update: Jun 2024
Source: Statista Market Insights
The Psychotic Disorders market in China is experiencing significant growth due to several factors.
Customer preferences: Chinese consumers are increasingly seeking mental health services and treatment options for psychotic disorders. This is partly due to a growing awareness and understanding of mental health issues in the country. As stigma surrounding mental health decreases, more individuals are seeking help and treatment for psychotic disorders. Additionally, the Chinese population is aging rapidly, which is leading to an increased prevalence of mental health conditions, including psychotic disorders.
Trends in the market: One of the key trends in the Psychotic Disorders market in China is the adoption of innovative treatment methods. Traditional Chinese medicine, including acupuncture and herbal remedies, is being integrated with Western medicine approaches to provide holistic and personalized treatment options for patients. This trend is driven by the belief that a combination of both approaches can lead to better outcomes for individuals with psychotic disorders.Another trend in the market is the increasing use of technology in the diagnosis and treatment of psychotic disorders. Telemedicine and online platforms are being utilized to provide remote consultations, therapy sessions, and monitoring for patients. This trend is particularly relevant in China, where access to mental health services may be limited in certain regions. The use of technology helps bridge the gap and ensures that individuals have access to the care they need.
Local special circumstances: China has a large population, and the demand for mental health services is growing rapidly. However, there is a shortage of mental health professionals in the country, particularly in rural areas. This presents a challenge in meeting the increasing demand for services. As a result, there is a need for innovative solutions and strategies to address this issue, such as the use of technology and the integration of traditional Chinese medicine.
Underlying macroeconomic factors: China's rapid economic growth and urbanization have contributed to the development of the Psychotic Disorders market. As the country becomes more affluent, individuals have more disposable income to spend on healthcare, including mental health services. Additionally, urbanization has led to increased stress and pressure on individuals, which can contribute to the development of mental health conditions.In conclusion, the Psychotic Disorders market in China is experiencing growth due to increasing customer preferences for mental health services, the adoption of innovative treatment methods, the use of technology, and the underlying macroeconomic factors of economic growth and urbanization. However, there are challenges in meeting the growing demand for services, particularly in rural areas. Creative solutions and strategies will be needed to address these challenges and ensure that individuals have access to the care they need.
Most recent update: Jun 2024
Source: Statista Market Insights
Data coverage:
Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.Modeling approach / Market size:
Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.Additional Notes:
The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.Notes: Based on data from IMF, World Bank, UN and Eurostat
Most recent update: Sep 2024
Source: Statista Market Insights